Because human breast cancer shows disruption in the myoepithelial layer (Cichon et al., 2010), we immunostained cells for the myoepithelial cell markers cytokeratin 5 (CK5) (Figure 1E) and p63 (Figure S2E). The gene discussed is KRT5; the disease is breast carcinoma.